Consumption trend studies feeding into zom stock forecast models show panel data indicating a 7% rise in average ticket size in urban markets. In the event this happens, sentiment for SurgePays could turn on a dime. Prior forecasts called for the company to earn as much as 80 cents per share in 2025. Hence, a positive turn of events would likely send this $3.19 per share stock back to double-digit price levels. Add in other catalysts, like SurgePays’ move into prepaid wireless, and there may be a longshot chance of an eventual tenfold move higher. With SURG, keep in mind the high risk, but don’t discount the potential high rewards. Zomedica stock is now back below $1. What's the 2025 forecast for ZOM stock? Will it rise or fall more from these levels? Medium-term zom stock forecast simulations point towards a gradual climb as industry consolidation improves competitive positioning.
